Shares of Arcturus Therapeutics Holdings Inc. (ARCT) are rising above 15% in pre-market today, after the company reported positive immunogenicity data from its preclinical study for its COVID-19 Vaccine. These data for LUNAR-COV19 were measured by Duke-NUS Medical School in Singapore.
from RTT - Before the Bell https://ift.tt/2VWPOeI
via IFTTT
No comments:
Post a Comment